FGL2 and metabolic dysfunction-associated steatotic liver disease: Fibrinogen-like protein 2 (FGL2), a ligand for FcγRIIb [71], was reported to be increased in patients with non-alcoholic fatty liver disease (NAFLD) [72] and liver cirrhosis [73].